PPII Coenzyme A Inc (CE)

Pro-Pointer, Inc. (PINKSHEETS: PPII), through its wholly owned subsidiary Coenzyme-A Technologies, Inc., is pleased to announce that during the first quarter of 2010 the demand for the Coenzyme-A product has continued to increase to the point where all of the current inventory was sold out. In short, Coenzyme-A duplicates biological functions used by the human body in the creation of cellular energy. Management further commented, "Our sales are going stronger than ever." Demand for the Coenzyme-A product has continued to grow over the past twelve years despite the sagging U.S. economy of late and the fact that all products are offered at premium price points.

Additionally, we are pleased to announce an update for our shareholders and perspective shareholders. "This is going to be a very exciting year for us," stated CEO Nickolaos D. Skouras, PhD. "We are looking forward to releasing several new innovative proprietary formulas all of which are in multibillion dollar markets."

The proposed marketing Plan for 2010 by Coenzyme-A Technologies will also include the launching of the revolutionary Anti-Aging skin care line the SKIN-MATRIX™. This line of cosmeceuticals (cosmetics and toiletries containing at least one bio-active ingredient), when properly marketed will have a tremendous impact on the cosmetic over the counter industry.

Cosmeceuticals represent the marriage of cosmetics and pharmaceuticals. According to industry experts, demand for cosmeceuticals in the U.S. will increase 7.4% annually to $9.4 billion through 2012, driven by an aging population seeking to maintain the appearance of youth. Examples of products typically labeled as cosmeceuticals include anti-aging creams and moisturizers. Cosmeceuticals are cosmetic products with biologically active ingredients having medical or drug-like benefits. Dermatological research suggests that the bioactive ingredients used in cosmeceuticals do indeed have benefits beyond the traditional moisturizer.

Lastly, we are excited about developments in the hair care, skin care and weight management markets utilizing our innovative proprietary formulations. As we approach launch dates for these new products you can look forward to frequent updates from management.

ABOUT COENZYME-A TECHNOLOGIES, INC. - Coenzyme-A Technologies, Inc. is an innovative company that has applied new technology to the formulation and manufacture of a series of proprietary products which address nutritional deficiencies that result from the stress of modern day living, chemical imbalances within the body, and the deleterious effects of aging. Coenzyme-A is the first nutraceutical product to combine nutritional components that can be successfully used by the body to support its manufacture and utilization of cellular Coenzyme-A (The Master Coenzyme). Coenzyme-A contains a specific set of substrates that are designed to assist the body in converting fats, carbohydrates and proteins into energy at the cellular level. See Company website -- www.coenzyme-a.com.

FORWARD LOOKING STATEMENTS The information contained in this news release, other than historical information, consists of forward-looking statements within the meaning of Section 27A of the Securities Act and Section 21E of the Exchange Act. These statements may involve risks and uncertainties that could cause actual results to differ materially from those described in such statements. Such forward-looking statements involve known and unknown risks and uncertainties, including all business uncertainties relating to product development, marketing, market acceptance, future capital requirements, competition in general and other factors that may cause actual results to be materially different from those described herein as anticipated, believed, estimated or expected. The Company is under no obligation to (and expressly disclaims any such obligation to) update or alter its forward-looking statements whether as a result of new information, future events or otherwise.

Add to Digg Bookmark with del.icio.us Add to Newsvine

INVESTOR RELATIONS at: InvestSource, Inc. 6352 Santa Ynez Drive Huntington Beach, CA 92647 Phone (714) 847-2460 Fax (714) 847-4987